NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-19 Cr | ₹12 Cr | ₹30 Cr | ₹41 Cr | ₹26 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-19 Cr |
Mar2023 | ₹12 Cr |
Mar2022 | ₹30 Cr |
Mar2021 | ₹41 Cr |
Mar2020 | ₹26 Cr |
How is Deferred Tax Assets / Liabilities of NATCO PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-19 Cr | Negative | |
Mar2023 | ₹12 Cr | -58.80 | |
Mar2022 | ₹30 Cr | -27.12 | |
Mar2021 | ₹41 Cr | 59.46 | |
Mar2020 | ₹26 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹14,567.1 Cr | -4.4% | 0.9% | -17.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹427,406.0 Cr | -2.7% | 3.9% | 19.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,113.0 Cr | 1% | 8.5% | 55.3% | Stock Analytics | |
CIPLA | ₹121,869.0 Cr | -2.6% | 3.9% | 6.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,345.0 Cr | -0.7% | 2.5% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,801.0 Cr | -1.9% | 0.9% | -7.8% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -4.4% |
0.9% |
-17.9% |
SENSEX | 0.6% |
6.2% |
8.4% |
You may also like the below Video Courses